{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T06:44:47Z","timestamp":1776840287085,"version":"3.51.2"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the efficacy and safety of ambroxol hydrochloride and clenbuterol hydrochloride oral solution (AHCHOS) in pediatric patients with wheezing disorders and provide a comprehensive evidence map of the current clinical status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A literature search was conducted in PubMed, Embase, Cochrane Library, CNKI, Wanfang, and CBM to identify randomized controlled trials (RCTs) evaluating the efficacy and safety of AHCHOS in children with wheezing disorders. The clinical status was descriptively summarized. Meta-analyses for efficacy and safety outcomes were performed using a random-effects model in Review Manager 5.4. Outcomes were treatment effectiveness, times to symptom and clinical sign resolution, length of hospital stay, and adverse events (AEs). All time-related outcomes were reported in days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 227 RCTs were included in the evidence mapping, 14 of which met the criteria for meta-analysis. Evidence mapping revealed a general increase in the number of studies from 2005 to a peak in 2012, followed by a decline. Most studies were conducted in eastern China, particularly in Henan Province. Meta-analysis results demonstrated that combination therapy with AHCHOS significantly improved the overall response rate [risk ratio (RR) 1.26, 95% confidence interval (CI) 1.10\u20131.44] and significant effective rate (RR 1.55, 95% CI 1.36\u20131.76). It also significantly reduced the duration (days) of coughing [mean difference (MD) \u22121.40, 95% CI \u22121.75 to \u22121.06], wheezing (MD \u22121.88, 95% CI \u22122.50 to \u22121.26), cough phlegm (MD \u22122.00, 95% CI \u22122.76 to \u22121.24), wet lung sounds (MD \u22121.82, 95% CI \u22122.33 to \u22121.30), pulmonary rales (MD \u22122.27, 95% CI \u22122.90 to \u22121.64), and hospital stay (MD \u22121.13, 95% CI \u22121.45 to \u22120.82). Furthermore, AHCHOS did not increase the risk of AEs compared with conventional treatment alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Combination therapy with AHCHOS was associated with modest but statistically significant improvements in symptom resolution and length of hospital stay compared with conventional treatment alone. However, all included studies were conducted in China, which may limit the generalizability of the findings. In addition, no definitive conclusions regarding safety could be drawn due to limited and inconsistent adverse event reporting. Further safety assessments in future trials are warranted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>The protocol has been registered on INPLASY (INPLASY202480121).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1588948","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:47:30Z","timestamp":1776836850000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Ambroxol hydrochloride and clenbuterol hydrochloride oral solution for wheezing disorders in children in China: evidence mapping and meta-analysis"],"prefix":"10.3389","volume":"14","author":[{"given":"Yongsheng","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Pulmonology, Machang Campus, Children\u2019s Hospital, Tianjin University\/ Tianjin Children\u2019s Hospital","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Run","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Machang Campus, Children\u2019s Hospital, Tianjin University\/ Tianjin Children\u2019s Hospital","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingxue","family":"Zou","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Machang Campus, Children\u2019s Hospital, Tianjin University\/ Tianjin Children\u2019s Hospital","place":["Tianjin, China"]},{"name":"Tianjin Key Laboratory of Birth Defects for Prevention and Treatment","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Machang Campus, Children\u2019s Hospital, Tianjin University\/ Tianjin Children\u2019s Hospital","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Machang Campus, Children\u2019s Hospital, Tianjin University\/ Tianjin Children\u2019s Hospital","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Machang Campus, Children\u2019s Hospital, Tianjin University\/ Tianjin Children\u2019s Hospital","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Zhai","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Machang Campus, Children\u2019s Hospital, Tianjin University\/ Tianjin Children\u2019s Hospital","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyin","family":"Mu","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Machang Campus, Children\u2019s Hospital, Tianjin University\/ Tianjin Children\u2019s Hospital","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingying","family":"An","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Machang Campus, Children\u2019s Hospital, Tianjin University\/ Tianjin Children\u2019s Hospital","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Pulmonology, Machang Campus, Children\u2019s Hospital, Tianjin University\/ Tianjin Children\u2019s Hospital","place":["Tianjin, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/j.1399-3038.2010.01035.x","article-title":"International study of wheezing in infants: risk factors in affluent and non-affluent countries during the first year of life","volume":"21","author":"Garcia-Marcos","year":"2010","journal-title":"Pediatr Allergy Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1136\/thx.2009.115188","article-title":"International prevalence of recurrent wheezing during the first year of life: variability, treatment patterns and use of health resources","volume":"65","author":"Mallol","year":"2010","journal-title":"Thorax"},{"key":"B3","doi-asserted-by":"publisher","first-page":"742581","DOI":"10.3389\/fmed.2021.742581","article-title":"Factors associated with childhood asthma and wheeze in Chinese preschool-aged children","volume":"8","author":"Deng","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1183\/09031936.00015712","article-title":"The impact of preschool wheezing patterns on health-related quality of life at age 4 years","volume":"41","author":"Hafkamp-de Groen","year":"2013","journal-title":"Eur Respir J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.chest.2020.08.2086","article-title":"Global physiology and pathophysiology of cough: part 1: cough phenomenology\u2014chest guideline and expert panel report","volume":"159","author":"Lee","year":"2021","journal-title":"Chest"},{"key":"B6","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.arbres.2013.09.011","article-title":"Cough in children","volume":"50","author":"Lamas","year":"2014","journal-title":"Arch Bronconeumol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2002990","DOI":"10.1183\/13993003.02990-2020","article-title":"European respiratory society guidelines for the management of children and adolescents with bronchiectasis","volume":"58","author":"Chang","year":"2021","journal-title":"Eur Respir J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ijpam.2019.02.003","article-title":"Wheezing in children: approaches to diagnosis and management","volume":"6","author":"Al-Shamrani","year":"2019","journal-title":"Int J Pediatr Adolesc Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.3760\/cma.j.issn.2095-428X.2018.19.005","article-title":"Guideline for rational use of medicines in children with wheezing disorders","volume":"33","year":"2018","journal-title":"Chin J Pract Pediatr"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1517\/17425255.4.8.1119","article-title":"Ambroxol in the 21st century: pharmacological and clinical update","volume":"4","author":"Malerba","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"936","DOI":"10.3390\/cells10040936","article-title":"The effect of the clenbuterol-\u03922-adrenergic receptor agonist on the peripheral blood mononuclear cells proliferation, phenotype, functions, and reactive oxygen species production in race horses in vitro","volume":"10","author":"Witkowska-Pi\u0142aszewicz","year":"2021","journal-title":"Cells"},{"key":"B12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/m18-0850","article-title":"Prisma extension for scoping reviews (Prisma-Scr): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The prisma 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br Med J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1002\/9781119536604.ch10","article-title":"Analysing data and undertaking meta-analyses","author":"Deeks","year":"2019","journal-title":"Cochrane Handbook Syst Rev Interv"},{"key":"B15","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The cochrane collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"Br Med J"},{"key":"B16","first-page":"421","article-title":"Analysis of curative effect of ambroterol on children with bronchiolitis","volume":"11","author":"Zhao","year":"2014","journal-title":"Chin Med Equip"},{"key":"B17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3969\/j.issn.1006-4931.2013.05.065","article-title":"Ambroterol oral solution for treatment of 30 cases of bronchiolitis","volume":"22","author":"Fang","year":"2013","journal-title":"China Pharm"},{"key":"B18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3969\/j.issn.1008-1089.2013.02.026","article-title":"Observation on the curative effect of ambroteroxor in treating 56 cases of severe pneumonia in children","volume":"41","author":"Hou","year":"2013","journal-title":"Chinese Jr Clin"},{"key":"B19","first-page":"2835","article-title":"Therapeutic effect of ambroterozox on 337 cases of bronchiolitis","volume":"9","author":"Zhang","year":"2012","journal-title":"Lab Med Clin"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.3969\/j.issn.1008-049X.2011.11.040","article-title":"Curative effect of ambroterol on bronchiolitis","volume":"14","author":"Yu","year":"2011","journal-title":"Front Pharm Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3969\/j.issn.1006-4931.2010.17.055","article-title":"Observation on the curative effect of ambroterol oral solution on relieving cough, expelling phlegm and relieving asthma","volume":"19","author":"Gao","year":"2010","journal-title":"China Pharm"},{"key":"B22","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3969\/j.issn.1000-3606.2010.05.023","article-title":"Analysis of ambrocol in treating infant bronchiolitis","volume":"28","author":"Lu","year":"2010","journal-title":"J Clin Pediatr"},{"key":"B23","doi-asserted-by":"publisher","first-page":"714","DOI":"10.3969\/j.issn.0253-4304.2009.05.058","article-title":"Curative effect of ambroterol oral liquid on 98 cases of bronchiolitis","volume":"31","author":"Wang","year":"2009","journal-title":"Guangxi Med J"},{"key":"B24","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3969\/j.issn.1671-4695.2008.05.110","article-title":"Clinical analysis of 100 cases of pediatric bronchiolitis treated with ambroterol hydrochloride oral liquid","volume":"7","author":"Zhou","year":"2008","journal-title":"J Clin Exp Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3969\/j.issn.1671-4695.2008.04.106","article-title":"Therapeutic effect of ambroterol oral liquid on 60 cases of bronchiolitis in children","author":"Wang","year":"2008","journal-title":"J Clin Exp Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3969\/j.issn.1672-108X.2007.03.019","article-title":"Observation on efficacy of ambroxol hydrochloride and clenbuterol hydrochloride on bronchiolitis","author":"Ma","year":"2007","journal-title":"J Pediatr Pharm"},{"key":"B27","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3969\/j.issn.1671-3826.2006.05.054","article-title":"Ambroterol oral liquid for the treatment of 30 cases of bronchopneumonia in children","author":"Wang","year":"2006","journal-title":"Clin J Med Officers"},{"key":"B28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3969\/j.issn.1003-6350.2008.03.067","article-title":"Therapeutic effect of ambroterol oral liquid in adjuvant treatment of 50 cases of infant pneumonia","volume":"19","author":"Long","year":"2008","journal-title":"Hainan Med J"},{"key":"B29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3969\/j.issn.1672-108X.2005.06.009","article-title":"Observation on efficacy of yitanjing on children with lower respiratory tract infection","volume":"11","author":"Huang","year":"2005","journal-title":"J Pediatr Pharm"},{"key":"B30","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3760\/cma.j.issn.2095-428X.2016.04.022","article-title":"Clinical research progress in pediatric wheezing disorders","volume":"31","author":"Liu","year":"2016","journal-title":"Chin J Pract Pediatr"},{"key":"B31","first-page":"3369","article-title":"Therapeutic effect of ambroterol oral liquid in the treatment of bronchiolitis","author":"Dong","year":"2008","journal-title":"J Modern Med Health"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.3969\/j.issn.1008-7664.2007.12.032","article-title":"Curative effect of ambroterol on Bronchiolitis","volume":"9","author":"Yuan","year":"2007","journal-title":"Zhejiang Clin Med J"},{"key":"B33","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3969\/j.issn.1008-049X.2015.03.021","article-title":"Clinical efficacy of ambroxol and clenbuterol combined with budesonide in the treatment of infants and young children with acute exacerbation asthma","volume":"18","author":"Xia","year":"2015","journal-title":"Front Pharm Sci"},{"key":"B34","first-page":"57","article-title":"Therapeutic effect of ambroxol oral solution on children with asthmatic bronchial pneumonia","volume":"56","author":"Wang","year":"2018","journal-title":"Chin Mod Doctor"},{"key":"B35","first-page":"210","article-title":"Evaluation of effects of ambrocol oral liquid on lower respiratory tract infection in children through meta-analysis","volume":"26","author":"Li","year":"2011","journal-title":"Chin J Pract Pediatr"},{"key":"B36","first-page":"62","article-title":"Evaluation of effects of ambroxol hydrochloride and clenbuterol hydrochloride oral solution on lower respiratory tract infection in children","volume":"42","author":"Men","year":"2014","journal-title":"Med Sci J Cent South Chin"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1517\/17460441.2011.629646","article-title":"Ambroxol: a multifaceted molecule with additional therapeutic potentials in respiratory disorders of childhood","volume":"6","author":"Paleari","year":"2011","journal-title":"Expert Opin Drug Discov"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1080\/14740338.2018.1533954","article-title":"Safety of ambroxol in the treatment of airway diseases in adult patients","volume":"17","author":"Cazan","year":"2018","journal-title":"Expert Opin Drug Saf"},{"key":"B39","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1378\/chest.80.6.881","article-title":"Effects of a Beta adrenergic drug and a secretolytic agent on regional mucociliary clearance in patients with cold","volume":"80","author":"Weiss","year":"1981","journal-title":"Chest"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1588948\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T05:47:44Z","timestamp":1776836864000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1588948\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":39,"alternative-id":["10.3389\/fped.2026.1588948"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1588948","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"article-number":"1588948"}}